[This corrects the article DOI: 10.3389/fcell.2023.1218807.]

Aleksandra Leszczynska

Ariel E. Feldstein

Christian Stoess

Lin Kui

Frontiers in Cell and Developmental Biology

English

Stoess, Christian

Leszczynska, Aleksandra

Kui, Lin

Feldstein, Ariel

eScholarship - University of California

UC San DiegoUC San Diego Previously Published WorksTitleCorrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis.Permalinkhttps://escholarship.org/uc/item/64t9k62sAuthorsStoess, ChristianLeszczynska, AleksandraKui, Linet al.Publication Date2024DOI10.3389/fcell.2024.1461581 Peer reviewedeScholarship.org Powered by the California Digital LibraryUniversity of CaliforniaCorrigendum: Pyroptosis andgasdermins—Emerging insightsand therapeutic opportunities inmetabolicdysfunction-associatedsteatohepatitisChristian Stoess1,2, Aleksandra Leszczynska1, Lin Kui1 andAriel E. Feldstein1*1Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA,United States, 2Department of Surgery, TUM School of Medicine, Klinikum rechts der Isar, TechnicalUniversity of Munich, Munich, GermanyKEYWORDSpyroptosis, gasdermins, liver, steatotic liver disease, steatohepatitis, MASH, MASLDA Corrigendum onPyroptosis and gasdermins—Emerging insights and therapeuticopportunities in metabolic dysfunction-associated steatohepatitisby Stoess C, Leszczynska A, Kui L and Feldstein AE (2023). Front. Cell Dev. Biol. 11:1218807. doi:10.3389/fcell.2023.1218807In the published article, there was an error in the Conflict of interest statement-author,Ariel E. Feldstein was erroneously excluded. The corrected Conflict of interest statementappears below.“Author AEF is an employee and stockholder of Novo Nordisk.The remaining authors declare that the research was conducted in the absence of anycommercial or financial relationships that could be construed as a potential conflictof interest.”The author apologizes for this error and states that this does not change the scientificconclusions of the article in any way. The original article has been updated.Publisher’s noteAll claims expressed in this article are solely those of the authors and do not necessarilyrepresent those of their affiliated organizations, or those of the publisher, the editors and thereviewers. Any product that may be evaluated in this article, or claim that may be made byits manufacturer, is not guaranteed or endorsed by the publisher.OPEN ACCESSAPPROVED BYFrontiers Editorial Office,Frontiers Media SA, Switzerland*CORRESPONDENCEAriel E. Feldstein,afeldstein@ucsd.eduRECEIVED 08 July 2024ACCEPTED 10 July 2024PUBLISHED 16 October 2024CITATIONStoess C, Leszczynska A, Kui L and Feldstein AE(2024), Corrigendum: Pyroptosis andgasdermins—Emerging insights and therapeuticopportunities in metabolic dysfunction-associated steatohepatitis.Front. Cell Dev. Biol. 12:1461581.doi: 10.3389/fcell.2024.1461581COPYRIGHT© 2024 Stoess, Leszczynska, Kui and Feldstein.This is an open-access article distributed underthe terms of the Creative Commons AttributionLicense (CC BY). The use, distribution orreproduction in other forums is permitted,provided the original author(s) and thecopyright owner(s) are credited and that theoriginal publication in this journal is cited, inaccordance with accepted academic practice.No use, distribution or reproduction ispermitted which does not comply with theseterms.Frontiers in Cell and Developmental Biology frontiersin.org01TYPE CorrectionPUBLISHED 16 October 2024DOI 10.3389/fcell.2024.1461581

Corrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis.

Directory of Open Access Journals

Corrigendum: Pyroptosis andgasdermins—Emerging insightsand therapeutic opportunities inmetabolicdysfunction-associatedsteatohepatitisChristian Stoess1,2, Aleksandra Leszczynska1, Lin Kui1 andAriel E. Feldstein1*1Department of Pediatric Gastroenterology, University of California, San Diego, San Diego, CA,United States, 2Department of Surgery, TUM School of Medicine, Klinikum rechts der Isar, TechnicalUniversity of Munich, Munich, GermanyKEYWORDSpyroptosis, gasdermins, liver, steatotic liver disease, steatohepatitis, MASH, MASLDA Corrigendum onPyroptosis and gasdermins—Emerging insights and therapeuticopportunities in metabolic dysfunction-associated steatohepatitisby Stoess C, Leszczynska A, Kui L and Feldstein AE (2023). Front. Cell Dev. Biol. 11:1218807. doi:10.3389/fcell.2023.1218807In the published article, there was an error in the Conflict of interest statement-author,Ariel E. Feldstein was erroneously excluded. The corrected Conflict of interest statementappears below.“Author AEF is an employee and stockholder of Novo Nordisk.The remaining authors declare that the research was conducted in the absence of anycommercial or financial relationships that could be construed as a potential conflictof interest.”The author apologizes for this error and states that this does not change the scientificconclusions of the article in any way. The original article has been updated.Publisher’s noteAll claims expressed in this article are solely those of the authors and do not necessarilyrepresent those of their affiliated organizations, or those of the publisher, the editors and thereviewers. Any product that may be evaluated in this article, or claim that may be made byits manufacturer, is not guaranteed or endorsed by the publisher.OPEN ACCESSAPPROVED BYFrontiers Editorial Office,Frontiers Media SA, Switzerland*CORRESPONDENCEAriel E. Feldstein,afeldstein@ucsd.eduRECEIVED 08 July 2024ACCEPTED 10 July 2024PUBLISHED 16 October 2024CITATIONStoess C, Leszczynska A, Kui L and Feldstein AE(2024), Corrigendum: Pyroptosis andgasdermins—Emerging insights and therapeuticopportunities in metabolic dysfunction-associated steatohepatitis.Front. Cell Dev. Biol. 12:1461581.doi: 10.3389/fcell.2024.1461581COPYRIGHT© 2024 Stoess, Leszczynska, Kui and Feldstein.This is an open-access article distributed underthe terms of the Creative Commons AttributionLicense (CC BY). The use, distribution orreproduction in other forums is permitted,provided the original author(s) and thecopyright owner(s) are credited and that theoriginal publication in this journal is cited, inaccordance with accepted academic practice.No use, distribution or reproduction ispermitted which does not comply with theseterms.Frontiers in Cell and Developmental Biology frontiersin.org01TYPE CorrectionPUBLISHED 16 October 2024DOI 10.3389/fcell.2024.1461581

Corrigendum: Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis

https://escholarship.org/content/qt64t9k62s/qt64t9k62s.pdf

Corrigendum: Pyroptosis and gasdermins-Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis.

Abstract

Similar works

Full text

Available Versions

eScholarship - University of California

Directory of Open Access Journals